Gene Biotherapeutics, Inc. Operating Lease Right-of-Use Assets
Gene Biotherapeutics, Inc. had Operating Lease Right-of-Use Assets of $145.02 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2022-04-14
- 2020-12-31: Operating Lease, Right-of-Use Asset $145.02K.
- 2020-09-30: Operating Lease, Right-of-Use Asset $162.09K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2020-12-31 | $145.02K 10-K/A · filed 2022-04-14 |
| 2020-09-30 | $162.09K 10-Q · filed 2021-10-27 |